ribociclib,palbociclib,fulvestrant
pfizer,novartis
['congrat']
maintain=great study. is the benefit due to the use of ribo after palbo or could any second cdk4/6i bring this benefit? #asco2022 congrats 
breast cancer immunotherapy investigator, mother, medical oncologist, PI at NKI, happy in Amsterdam